Trial
NCT05203705
Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shanghai Hengrui Pharmaceutical Co., Ltd.
Collaborators
—
Condition
Prevention of Venous Thrombosis After TKA
Intervention
SHR2285 tablet
Why stopped
Adjustment of the sponsor's R\&D strategy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-17